Qure Ventures

CoreMap, Inc. is dedicated to enhancing patient outcomes through advanced diagnostic technology tailored for electrophysiologists treating atrial fibrillation. Founded in 2016 and based in Winooski, Vermont, the company has developed a micro-electrode solution that allows for sequential mapping of tissue properties. This innovative technology addresses critical challenges in atrial fibrillation treatment, specifically poor spatial resolution and inadequate sample density. CoreMap's ultra-high resolution electrodes provide detailed insights into cardiac activation, even in the presence of fibrillation, thereby enabling medical practitioners to offer more effective treatment options for patients.

Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions aimed at improving clinical outcomes for individuals with chronic conditions. The company's hyper-personalized engagement platform offers tailored recommendations that consider the appropriate timing, tone, and real-world context for each patient's health journey. This approach enables pharmaceutical companies, medical device manufacturers, payers, and healthcare providers to foster continuous relationships and effectively engage with patients at scale, ultimately supporting individuals in achieving their health goals.

Carevive Systems, Inc. is a company that develops a platform designed to enhance cancer care delivery and patient engagement. The platform includes Carevive PROmpt, which serves as a cancer clinical practice and patient engagement software for treatment planning, symptom management, and survivorship care, as well as offering analytics and evidence-based care plans. It also features a Treatment Care Plans engine, which utilizes rules technology for personalized treatment strategies, and a Navigation/Care Coordination module that facilitates patient eligibility tracking and care plan adherence. Additionally, Carevive Systems provides tools for risk stratification, symptom triage, and patient symptom trending, allowing clinicians to monitor patient progress effectively. The company, based in North Miami, Florida, was incorporated in 2013 and rebranded from On Q Health, Inc. in 2015. Through its solutions, Carevive Systems aims to improve clinical outcomes and support oncology practices in adapting to value-based care models.

CoreMap, Inc. is dedicated to enhancing patient outcomes through advanced diagnostic technology tailored for electrophysiologists treating atrial fibrillation. Founded in 2016 and based in Winooski, Vermont, the company has developed a micro-electrode solution that allows for sequential mapping of tissue properties. This innovative technology addresses critical challenges in atrial fibrillation treatment, specifically poor spatial resolution and inadequate sample density. CoreMap's ultra-high resolution electrodes provide detailed insights into cardiac activation, even in the presence of fibrillation, thereby enabling medical practitioners to offer more effective treatment options for patients.

CyberMDX is a leader in IoT security focused on safeguarding healthcare delivery worldwide. The company offers a cloud-based cybersecurity platform that addresses the vulnerabilities associated with the Internet of Medical Things. Its solution enables continuous discovery and real-time monitoring of medical device security, allowing for the identification and assessment of potential threats. By employing micro-segmentation policies, CyberMDX isolates asset-based threats, facilitating improved security and operational continuity in healthcare settings. The platform features agentless asset identification and inventorying, which enhances visibility and helps detect malicious activities within device behavior and network hygiene. Deployed globally, CyberMDX is designed to seamlessly integrate with existing healthcare environments, providing a scalable and user-friendly solution for healthcare organizations.

Sweetch is a behavioral science company that utilizes artificial intelligence and emotional intelligence to provide digital therapeutic solutions aimed at improving clinical outcomes for individuals with chronic conditions. The company's hyper-personalized engagement platform offers tailored recommendations that consider the appropriate timing, tone, and real-world context for each patient's health journey. This approach enables pharmaceutical companies, medical device manufacturers, payers, and healthcare providers to foster continuous relationships and effectively engage with patients at scale, ultimately supporting individuals in achieving their health goals.

CyberMDX is a leader in IoT security focused on safeguarding healthcare delivery worldwide. The company offers a cloud-based cybersecurity platform that addresses the vulnerabilities associated with the Internet of Medical Things. Its solution enables continuous discovery and real-time monitoring of medical device security, allowing for the identification and assessment of potential threats. By employing micro-segmentation policies, CyberMDX isolates asset-based threats, facilitating improved security and operational continuity in healthcare settings. The platform features agentless asset identification and inventorying, which enhances visibility and helps detect malicious activities within device behavior and network hygiene. Deployed globally, CyberMDX is designed to seamlessly integrate with existing healthcare environments, providing a scalable and user-friendly solution for healthcare organizations.

BrainQ is a company founded in 2016 and headquartered in Jerusalem, Israel, that focuses on developing precision neurology therapies for individuals with neuro disorders. The company operates a neuro recovery platform that employs a brain-computer interface (BCI) approach to target damaged neuronal networks. By integrating machine learning algorithms with neuroscience, BrainQ extracts biological insights that inform the creation of tailored therapies. These innovations aim to facilitate neuro recovery and enhance the quality of life for patients, enabling them to live more independent and fulfilling lives.